You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

NULYTELY Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Nulytely, and when can generic versions of Nulytely launch?

Nulytely is a drug marketed by Braintree and is included in one NDA.

The generic ingredient in NULYTELY is polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride. There are four hundred and twenty-one drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for NULYTELY?
  • What are the global sales for NULYTELY?
  • What is Average Wholesale Price for NULYTELY?
Summary for NULYTELY
Drug patent expirations by year for NULYTELY
Drug Prices for NULYTELY

See drug prices for NULYTELY

Recent Clinical Trials for NULYTELY

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Gastroenterology Services, Ltd.
ColonaryConcepts LLCPhase 2
Instituto Nacional de Ciencias Medicas y Nutricion Salvador ZubiranPhase 3

See all NULYTELY clinical trials

US Patents and Regulatory Information for NULYTELY

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Braintree NULYTELY polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride FOR SOLUTION;ORAL 019797-001 Apr 22, 1991 AA RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Braintree NULYTELY-FLAVORED polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride FOR SOLUTION;ORAL 019797-002 Nov 18, 1994 AA RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.